Metacrine raises $22M to advance liver drug for humans

Metacrine, a San Diego biotech developing drugs for metabolic diseases, said it has raised $22 million from venture capital investors.

The financing will help privately held Metacrine advance its program to treat liver diseases, the company said. It is developing a drug now called MET409 for potential…